About Affymetrix

Stock Quote

Security
AFFX (Common Stock)
$14.01
+0.14%
Current Day's High
14.05
Current Day's Low
14.00
Current Day's Volume
5,030,402
Last Trade
Mar 31 16 4:00 p.m. ET
Exchange
NASDAQ

The stock price performance shown on the quote above is not necessarily indicative of future price performance

Investors

Investor Relations Contact

Doug Farrell
VP Investor Relations & Treasury
Tel. 408-731-5285
Fax. 408-731-5750
investor@affymetrix.com

Investor Kit

Download Documentation2014 Annual Report
Download Documentation2015 Proxy

Affymetrix Provides Notice to Holders of its Convertible Notes

 Click here for PDF

Santa Clara, Calif.—March 31, 2016 – The completion of the previously announced acquisition of Affymetrix, Inc. ("Affymetrix") by Thermo Fisher Scientific Inc. constitutes a Fundamental Change and Make-Whole Fundamental Change under the Indenture, dated as of June 25, 2012, as supplemented (the "Indenture"), between Affymetrix and The Bank of New York Mellon Trust Company, N.A., as Trustee (the "Trustee"), relating to Affymetrix' 4.00% Convertible Senior Notes due 2019 (the "Notes"). The Effective Date (as defined in the Indenture) of the Fundamental Change and Make-Whole Fundamental Change was March 31, 2016. On March 31, 2016, Affymetrix provided written notice to holders of the Notes of the Fundamental Change and the Make-Whole Fundamental Change, and the right at the option of each holder to require Affymetrix to repurchase its Notes or to surrender its Notes for conversion. A copy of the written notice has been delivered to the Trustee and is provided here.

Recent News

TitleDate
Thermo Fisher Scientific Completes Acquisition of Affymetrix Following Approval of Transaction by Affymetrix Stockholders
WALTHAM, Mass. & SANTA CLARA, Calif.--(BUSINESS WIRE)--Mar. 31, 2016-- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, and Affymetrix, Inc. (NASDAQ: AFFX), a leading provider of cellular and genetic analysis products, today announced that Thermo Fisher has completed its previously announced acquisition of Affymetrix for $14.00 per share in cash, for a total purchase price of approximately $1.3 billion. Completion of th... 
03/31/16
Affymetrix Receives Grant for Non-Invasive Genomic Profiling of Bladder Cancer
SANTA CLARA, Calif.--(BUSINESS WIRE)--Mar. 8, 2016-- Affymetrix Inc. (NASDAQ:AFFX) today announced that it has received a grant from Innovate UK (IUK) to demonstrate the health and economic value of utilizing the company’s OncoScan® FFPE Assay Kit for non-invasive genomic profiling of bladder cancer from urine samples. Bladder cancer is the seventh most common cancer in the western world, with over 10,000 new cases diagnosed in the UK each year. P... 
03/08/16
Groupe Grimaud Chooses Affymetrix Genotyping Arrays for Poultry Breeding Business
SANTA CLARA, Calif.--(BUSINESS WIRE)--Feb. 24, 2016-- Affymetrix, Inc. (NASDAQ:AFFX) announced today that one of the world’s largest producers of breeding chickens – Roussay, France-based Groupe Grimaud – will use the Axiom® genotyping platform from Affymetrix in its genomic selection and poultry breeding program. The Grimaud Novogen and Hubbard divisions will be incorporating the Affymetrix technology, and the company is already using a rabbit ge... 
02/24/16
Bio-Genesys and Affymetrix Partner to Offer Animal Genomic Testing Services to Professional Farming Operations
SANTA CLARA, Calif.--(BUSINESS WIRE)--Jan. 12, 2016-- Affymetrix, Inc. (NASDAQ:AFFX) and United Kingdom-based Bio-Genesys Diagnostics announced today that they have entered a partnership to offer commercial genotyping services. Under the terms of the agreement, the genetic testing services offered by Bio-Genesys Diagnostics for cattle, pigs, goats, sheep, and camelids will be run exclusively on Affymetrix’s technology. The partnership leverages th... 
01/12/16
Affymetrix Expands Agrigenomics Genotyping Portfolio with New Targeted Sequencing Solution and Array Formats
SANTA CLARA, Calif.--(BUSINESS WIRE)--Jan. 7, 2016-- Affymetrix, Inc. (NASDAQ:AFFX) is introducing several new agrigenomic genotyping solutions this week at the annual Plant and Animal Genome Conference (PAG XXIV). Following the company’s acquisition of Eureka Genomics in mid-2015, Affymetrix is introducing Eureka™ Genotyping Solution for low-cost, low-plex genotyping by sequencing (GBS). The company is also introducing two new array configuration... 
01/07/16
Affymetrix and Reveal Biosciences Partner to Offer RNA ISH Tissue Staining, Imaging, and Image Analysis Services
SANTA CLARA, Calif. & SAN DIEGO--(BUSINESS WIRE)--Dec. 2, 2015-- Affymetrix Inc. (NASDAQ:AFFX) and Reveal Biosciences LLC, an advanced tissue technologies company, today announced a partnership agreement through which Reveal will use Affymetrix ViewRNA® ISH products for tissue samples to provide RNA in situ hybridization (ISH) staining, imaging, and quantification services using the company’s proprietary image analysis software, ImageDx... 
12/02/15
USDA, Aviagen, Hendrix Genetics, and Affymetrix Launch Axiom® Turkey Genotyping Array for Improved Breeding Outcome
SANTA CLARA, Calif.--(BUSINESS WIRE)--Nov. 19, 2015-- Affymetrix, Inc. (NASDAQ: AFFX) introduces Axiom® Turkey Genotyping Array, developed in collaboration with the United States Department of Agriculture – Agricultural Research Service (USDA-ARS) along with Aviagen and Hendrix Genetics. The array will help breeders better understand the genetics of turkeys in order to improve meat characteristics and health. It will enable scientist... 
11/19/15
Affymetrix and XRGenomics LTD to Collaborate on Development of a New Generation of Diagnostic Tests for Age-Related Diseases
SANTA CLARA, Calif.--(BUSINESS WIRE)--Nov. 5, 2015-- Affymetrix, Inc. (NASDAQ: AFFX) and XRGenomics LTD, a UK based biotechnology company, announced today that they will collaborate on research and development of a new generation of diagnostic tests for age-related diseases. Over 50% of healthcare costs are spent on those aged 65 and older and according to the G8 Summit 2013, age-related diseases could bankrupt Western medicine by 2050. New ... 
11/05/15
Affymetrix and Athletigen Partner to Advance Genetics in Human Athletic Performance
SANTA CLARA, Calif. & HALIFAX, Nova Scotia--(BUSINESS WIRE)--Oct. 27, 2015-- Affymetrix Inc. (NASDAQ: AFFX) and Athletigen Technologies Inc., a direct-to-consumer sports genetics company, today announced a global partnership agreement. Under the agreement, Athletigen will use Affymetrix Axiom® genotyping platform for its sports-related DNA analysis service. This Smart News Release features multimedia. View the full release here: http://www.busines... 
10/27/15
Affymetrix and Luminex Announce Distribution Agreement for Multiplexed Assay Instrument Platform
SANTA CLARA, Calif. & AUSTIN, Texas--(BUSINESS WIRE)--Oct. 15, 2015-- Affymetrix Inc. (NASDAQ: AFFX) and Luminex Corporation (NASDAQ: LMNX) today announced a distribution agreement under which eBioscience, a business unit of Affymetrix, will sell Luminex’s MAGPIX®, Luminex® 200™ and FLEXMAP 3D® multiplexed assay platforms in specified countries in the Americas, Asia and Europe. Affymetrix will sell the Luminex instruments together with ... 
10/15/15
Affymetrix Genotyping Array Technology Powers Newly Published Work on Transplantation Genetics
Papers in Transplantation and Genomic Medicine Describe Creation and Testing of Customized Transplant Array Santa Clara, CA, October 6, 2015 – Affymetrix, Inc. (NASDAQ: AFFX) announced today that its Axiom® high-throughput genotyping technology was instrumental in two transplantation peer-reviewed publications issued this month by an international team of surgeons and scientists. The consortium – International Genetics and Translational Research in Transplantation Network (iGeneTRAiN) –... 
10/06/15
New Affymetrix HLA Analysis Software Quickly Delivers High-Resolution HLA Types From Genotyping Data
SANTA CLARA, Calif.--(BUSINESS WIRE)--Oct. 6, 2015-- Affymetrix (NASDAQ: AFFX) introduces Axiom™ HLA Analysis software for automated, high-resolution human leukocyte antigen (HLA) typing from any genotyping dataset containing coverage of the extended major histocompatibility complex (MHC) region. The software’s unique imputation algorithm enables 4-digit HLA typing from genome-wide association studies (GWAS), combining genotyping and high-resoluti... 
10/06/15
Affymetrix Introduces Axiom Transplant Genotyping Array for Genomic Profiling of Immune-Related Markers
SANTA CLARA, Calif.--(BUSINESS WIRE)--Oct. 6, 2015-- Affymetrix (NASDAQ:AFFX) introduces Axiom® Transplant Genotyping Array, designed in collaboration with an international team of surgeons and scientists for research studies to improve transplantation success and individualize donor/patient selection and treatment. The array comprises ~ 780,000 markers, including over 30,000 variants that may contribute to transplant rejection or other complicati... 
10/06/15
New 384-well Assay from Affymetrix Delivers High-Throughput, PCR-free Gene Expression Analysis
SANTA CLARA, Calif., September 22, 2015 –Affymetrix (Nasdaq: AFFX) announces the extension of its QuantiGene® Singleplex Assay for PCR-free gene expression measurement to include a 384-well format that is easily automatable for high-throughput compound screening. The easy-to-use, high-sensitivity assay measures gene expression with minimal sample preparation, using branched DNA for signal amplification. A key feature of the assay is that it does not require RNA or DNA purification, revers... 
09/22/15
Green Super Rice Project Funded by the Chinese Government and the Bill & Melinda Gates Foundation Selects Affymetrix Axiom® Genotyping Platform for Developing New Rice Varieties
SANTA CLARA, Calif.--(BUSINESS WIRE)--Sep. 21, 2015-- Affymetrix, Inc. (NASDAQ:AFFX) announced today that it has been selected as the genotyping supplier by the Green Super Rice project coordinated by the Chinese Academy of Agricultural Sciences as part of their effort to develop, within the next three years, at least fifteen new rice varieties and deliver them to small-hold farmers in 16 countries in Africa and Asia, including China. Thi... 
09/21/15

Receive Email Alerts

Sign up to receive e-mail alerts whenever Affymetrix posts new information to the site. Just enter your e-mail address and click Submit.

Back to Top >